BRIEF published on 11/12/2025 at 08:40, 22 days 21 hours ago Softing AG Reports on Q3 and First 9 Months of 2025 Industrial Automation Softing AG 2025 Financial Performance Automotive Segment IT Networks
PRESS RELEASE published on 11/12/2025 at 08:35, 22 days 21 hours ago Softing AG: Interim Statement on the 3rd Quarter and First 9 Months of 2025 Softing AG reports positive trend with 14% increase in incoming orders for the 3rd quarter and first 9 months of 2025, expecting revenue growth in 2026 across Industrial, Automotive, and IT Networks segments Revenue Growth 2025 Industrial Automation Softing AG Incoming Orders
BRIEF published on 09/29/2025 at 12:58, 2 months 5 days ago Softing AG Lowers 2025 Revenue and EBIT Forecasts Financial Performance Revenue Forecast Softing AG 2025 Projections EBIT Revision
PRESS RELEASE published on 09/29/2025 at 12:53, 2 months 5 days ago EQS-Adhoc: Softing AG Revises Full-Year Guidance Softing AG revises full-year guidance for 2025 due to lower than expected sales and earnings in August and September, uncertain if original targets can be achieved 2025 Full-year Guidance Softing AG Revises Forecast Change
BRIEF published on 05/15/2025 at 08:09, 6 months 20 days ago Softing AG: Mixed Results in Q1 2025 Amid Economic Challenges Softing AG Q1 2025 Revenue Challenges Automotive Growth Industrial Decline
PRESS RELEASE published on 05/15/2025 at 08:04, 6 months 20 days ago Softing AG: Interim Statement on the 1st Quarter of 2025 Softing AG releases Q1 2025 Interim Statement, reporting mixed performance in Automotive and Industrial segments. Automotive revenue up by 50%, Industrial revenue down. Group revenue at EUR 22.3 million Automotive Interim Statement Softing AG Q1 2025 Industrial
BRIEF published on 12/12/2024 at 14:45, 11 months 23 days ago Softing AG Revises Annual Forecast Amidst Market Challenges Revenue Forecast Market Challenges Softing AG Investment Postponements EBIT Revision
PRESS RELEASE published on 12/12/2024 at 14:40, 11 months 23 days ago EQS-Adhoc: Softing AG Revises Full-Year Guidance Softing AG revises full-year guidance. Due to weakened customer demand, sales and earnings expectations adjusted. Operating EBIT now expected between EUR 2-2.5M Operating EBIT Full-year Guidance Softing AG Revises Weakened Demand
BRIEF published on 11/12/2024 at 08:35, 1 year ago Softing AG Reports Decline in Revenue Amidst Economic Challenges Economic Challenges Earnings Decline 2024 Financial Outlook Softing AG Automotive Segment Growth
PRESS RELEASE published on 11/12/2024 at 08:30, 1 year ago Interim Statement on the 3rd Quarter and First 9 Months of 2024 Softing AG reports a 20% decrease in revenue in the first 9 months of 2024 due to global economic weakness. Key markets impacted include mechanical engineering and IT infrastructure Revenue Decrease IT Infrastructure Global Economy Softing AG Mechanical Engineering
Published on 12/05/2025 at 02:35, 3 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 20 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 3 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
